Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1974 Aug;37(8):869–873. doi: 10.1136/jnnp.37.8.869

A trial of corticotrophin gelatin injection in acute optic neuritis

A N Bowden 1, P M A Bowden 1, A I Friedmann 1, G D Perkin 1, F C Rose 1
PMCID: PMC494799  PMID: 4371063

Abstract

The effect of a 30 day course of corticotrophin gelatin injections on the natural history of acute unilateral optic neuritis in 27 patients is reported. A further 27 patients received inert injections in a double-blind control. Measurements were made on visual acuity, visual field, macular threshold, and colour vision, and the development of optic atrophy and other neurological episodes was recorded. No significant differences were found between treated and control groups at intervals up to two years from the start of the trial. The criteria for inclusion of patients are given and it is concluded that corticotrophin has no effect on the natural history of the condition as defined.

Full text

PDF
869

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALEXANDER L., CASS L. J. The present status of ACTH therapy in multiple sclerosis. Ann Intern Med. 1963 Mar;58:454–471. doi: 10.7326/0003-4819-58-3-454. [DOI] [PubMed] [Google Scholar]
  2. Bradley W. G., Whitty C. W. Acute optic neuritis: its clinical features and their relation to prognosis for recovery of vision. J Neurol Neurosurg Psychiatry. 1967 Dec;30(6):531–538. doi: 10.1136/jnnp.30.6.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Friedmann A. I. Serial analysis of changes in visual field defects, employing a new instrument, to determine the activity of diseases involving the visual pathways. Ophthalmologica. 1966;152(1):1–12. doi: 10.1159/000304950. [DOI] [PubMed] [Google Scholar]
  4. HYLLESTED K., MOLLER P. M. Follow-up on patients with a history of optic neuritis. Acta Ophthalmol (Copenh) 1961;39:655–662. doi: 10.1111/j.1755-3768.1961.tb00280.x. [DOI] [PubMed] [Google Scholar]
  5. LYNN B. H. Retrobulbar neuritis. A survey of the present condition of cases occurring over the last fifty-six years. Trans Ophthalmol Soc U K. 1959;79:701–716. [PubMed] [Google Scholar]
  6. MILLER H., NEWELL D. J., RIDLEY A. Multiple sclerosis. Treatment of acute exacerbations with corticotrophin (A.C.T.H.). Lancet. 1961 Nov 18;2(7212):1120–1122. doi: 10.1016/s0140-6736(61)91030-3. [DOI] [PubMed] [Google Scholar]
  7. Millar J. H., Vas C. J., Noronha M. J., Liversedge L. A., Rawson M. D. Long-term treatment of multiple sclerosis with corticotrophin. Lancet. 1967 Aug 26;2(7513):429–431. doi: 10.1016/s0140-6736(67)90850-1. [DOI] [PubMed] [Google Scholar]
  8. Rawson M. D., Liversedge L. A., Goldfarb G. Treatment of acute retrobulbar neuritis with corticotrophin. Lancet. 1966 Nov 12;2(7472):1044–1046. doi: 10.1016/s0140-6736(66)92025-3. [DOI] [PubMed] [Google Scholar]
  9. Rawson M. D., Liversedge L. A. Treatment of retrobulbar neuritis with corticotrophin. Lancet. 1969 Jul 26;2(7613):222–222. doi: 10.1016/s0140-6736(69)91469-x. [DOI] [PubMed] [Google Scholar]
  10. Rinne U. K., Sonninen V., Tuovinen T. Corticotrophin treatment in multiple sclerosis. Acta Neurol Scand. 1968;44(2):207–218. doi: 10.1111/j.1600-0404.1968.tb05567.x. [DOI] [PubMed] [Google Scholar]
  11. WYBAR K. C. The ocular manifestations of disseminated sclerosis. Proc R Soc Med. 1952 May;45(5):315–320. doi: 10.1177/003591575204500513. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES